Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Alibaba’s Price War Strategy Backfires as Losses Mount Beyond Forecasts

Robert Sasse by Robert Sasse
August 19, 2025
in Stocks
0
Alibaba Stock
0
SHARES
18
VIEWS
Share on FacebookShare on Twitter

China’s e-commerce titan Alibaba finds itself embroiled in an increasingly costly battle for market dominance, with financial repercussions far exceeding initial projections. What began as a strategic offensive has morphed into a concerning drain on resources, with market experts now anticipating losses surpassing 30 billion yuan—nearly double earlier estimates.

Delivery Market Competition Reaches Fever Pitch

The intensifying rivalry among China’s online retail giants has taken a dramatic turn following JD.com’s worse-than-expected earnings report. This development prompted JPMorgan to revise its Alibaba assessment downward, now forecasting third-quarter losses exceeding 30 billion yuan—a stark contrast to its previous 17 billion yuan estimate.

At the heart of the financial hemorrhage lies an escalating subsidy war between Alibaba, JD.com, and Meituan. The competitors are burning through billions in discount campaigns and customer incentives to protect—or poach—market share. While JD.com may reconsider its participation due to mounting financial strain, Alibaba appears committed to sustaining this costly conflict for the foreseeable future.

Profitability Takes a Severe Hit

The price war’s impact on Alibaba’s financial health has drawn serious concern from analysts. Mizuho Securities slashed its price target from $160 to $149, citing "significant margin compression" as a primary risk. The firm’s revised EBITDA projection for the June quarter paints a particularly grim picture, dropping from 55 billion to 45 billion RMB.

Should investors sell immediately? Or is it worth buying Alibaba?

Market strategists anticipate this margin pressure will persist through 2026, indicating Alibaba’s willingness to sacrifice short-term profitability for long-term market positioning. The company’s aggressive discounting strategy continues to erode earnings, with no immediate relief in sight.

All Eyes on August Earnings Report

Investors await Alibaba’s June quarter results, scheduled for release on August 29, with heightened anticipation. These figures will reveal the true financial toll of the subsidy battles and determine whether the company’s aggressive tactics are yielding measurable market gains—or potentially steering the business toward unsustainable losses.

The upcoming report may serve as a turning point, potentially prompting strategic reassessments if losses continue outpacing projections. Market watchers will scrutinize whether Alibaba’s market share gains justify the extraordinary financial outlay required to maintain its competitive offensive.

Ad

Alibaba Stock: Buy or Sell?! New Alibaba Analysis from August 7 delivers the answer:

The latest Alibaba figures speak for themselves: Urgent action needed for Alibaba investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 7.

Alibaba: Buy or sell? Read more here...

Tags: Alibaba
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Robinhood Stock

Cathie Wood Doubles Down on Robinhood Despite Insider Sell-Off

Nio Stock

Nio Slashes EV Prices Amid Intensifying Rivalry with Tesla

Tilly's Stock

Tilly's Stock Faces Pivotal Test Amid Leadership Transition

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com